Comparison of cardiovascular effects of SGB-1534 and prazosin, selective .ALPHA.1-adrenoceptor antagonists, in anesthetized dogs.
スポンサーリンク
概要
- 論文の詳細を見る
The cardiovascular effects of a novel antihypertensive agent, SGB-1534, and its α<SUB>1</SUB>-adrenoceptor antagonism in the renal vasculature were investigated in anesthetized dogs and compared with those of prazosin. The doses ofSGB-1534 (1-100 μg/kg) and prazosin (3-300 μg/kg) were increased by afactor of about 3 and given i.v. in a cumulative way. SGB-1534 produced dose-dependent decreases in systemic (systolic, mean and diastolic) blood pressure (SBP), left ventricular (LV) systolic and end-diastolic pressure, and femoral vascular resistance, accompanied by no changes in heart rate (HR), LVdP/dt max and pressurerate product. Femoral blood flow tended to increase, but the change was not significant. Renal blood flow and the vascular resistance remained virtually unchanged.Similar results were obtained with prazosin for the cardiovascular parameters testedexcept diastolic SBP and femoral vascular resistance, in which no significant changes occurred. SGB-1534 and prazosin dose-dependently attenuated renal vasoconstrictor responses to a relatively selective α<SUB>1</SUB>-adrenoceptor agonist, phenylephrine (3 or 10 μg) given into the renal artery. When the doses that attenuated the vasoconstrictor response to phenylephrine by 50% were compared on a weight basis, α<SUB>1</SUB>-adrenoceptor antagonistic activity of SGB-1534 was approximately 25 times more potent than that of prazosin in the renal vasculature of dogs. Both α<SUB>1</SUB>-adrenoceptor antagonists showed a significant positive correlation between the systemic hypotensive effects and the α<SUB>1</SUB>-adrenoceptor antagonism in the renal vasculature.Thus, it seems that SGB-1534, like prazosin, has a balanced effect decreasing afterload as well as preload and that the hypotension is mainly due to the α<SUB>1</SUB>-adrenoceptor antagonism in the peripheral vasculatures.
- 公益社団法人 日本薬理学会の論文
著者
-
NABATA Hiroyuki
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokyo
-
SAKAI Kazushige
Departinent of Pharmacology, Research Laboratories, Chugai Pharmaceutical Co.
-
NABATA Hiroyuki
Department of Pharmacology, Research Laboratories, Chugai Pharmaceutical Co., Ltd.
-
IMAGAWA Jun-ichi
Department of Pharmacology, Tohoku University School of Medicine
-
IMAGAWA Jun-ichi
Department of Pharmacology, Research Laboratories, Chugai Pharmaceutical Co., Ltd.
関連論文
- EFFECTS OF A NEW CORONARY VASODILATOR, N-(2-HYDROXYETHYL)NICOTINAMIDE NITRATE (SG-75) AND NITROGLYCERIN ON CARDIOVASCULAR HEMODYNAMICS IN YOUNG AND AGED BEAGLE DOGS
- PHARMACOLOGICAL STUDIES OF PANAX GINSENG ROOT: ESTIMATION OF PHARMACOLOGICAL ACTIONS OF PANAX GINSENG ROOT
- A POSSIBLE PURINERGIC MECHANISM FOR REACTIVE ISCHEMIA IN ISOLATED, CROSS-CIRCULATED RAT KIDNEY
- TRYPTAMINERGIC VASOCONSTRICTION INDUCED BY ADENOSINE IN THE FEMORAL VASCULAR BED OF THE RAT
- EFFECTS OF N-(2-HYDROXYETHYL)NICOTINAMIDE NITRATE (SG-75) ON METHACHOLINE-INDUCED ECG CHANGES IN INTACT ANESTHETIZED RATS
- FEMORAL VASCULAR RESPONSES TO PURINE AND PYRIMIDINE DERIVATIVES: RELEASE OF 5-HYDROXYTRYPTAMINE BY PURINE DERIVATIVES IN ISOLATED, CROSS-CIRCULATED RAT HINDLIMB
- DEVELOPMENT OF TOLERANCE AND A NEW CORONARY VASODILATOR, N-(2-HYDROXYETHYL)NICOTINAMIDE NITRATE (SG-75): A COMPARISON WITH NITROGLYCERIN
- DEVELOPMENT OF CORONARY COLLATERAL CIRCULATION IN MINIATURE SWINE AND EFFECTS OF SEVERAL DRUGS
- THE HYPOTENSIVE MECHANISMS OF THE NEW ANTI-ANGINAL DRUG, N-(2-HYDROXYETHYL)NICOTINAMIDE NITRATE (SG-75) IN BEAGLE DOGS
- PHARMACODYNAMIC AND METABOLISM STUDIES ON A NEW CORONARY VASODILATOR, N-(2-HYDROXYETHYL) NICOTINAMIDE NITRATE (SG-75)
- VASCULARLY PERFUSED RAT SMALL INTESTINE: A RESEARCH MODEL FOR DRUG ABSORPTION
- POSITIVE AND NEGATIVE CHRONOTROPIC RESPONSE OF THE S-A NODE TO OXYFEDRINE
- PHARMACOLOGICAL STUDIES OF NEUTRAL SAPONINS (GNS) OF PANAX GINSENG ROOT
- PHARMACOLOGICAL FEATURES OF PERIPHERAL VASCULAR BEDS OF BEAGLES
- Improvement of Cardiac Performance by Pimobendan, a New Cardiotonic Drug, in the Experimental Failing Dog Heart.
- Protective Effects of the Antianginal Agent Nicorandil on Arachidonate-Induced Sudden Death in Rats: Comparison with Several Antianginal Agents and Cyclooxygenase Inhibitors
- Investigations into the mechanism of the antihypertensive effect of SGB-1534, a novel .ALPHA.1-adrenoceptor antagonist, in rats.
- Antithrombotic and ulcerogenic effects of fenflumizole, a new anti-inflammatory imidazole derivative, in rats.
- Antiplatelet effects of fenflumizole, a new anti-inflammatory drug, in dogs.
- Comparison of cardiovascular effects of SGB-1534 and prazosin, selective .ALPHA.1-adrenoceptor antagonists, in anesthetized dogs.
- Comparative effects of nicorandil and nitroglycerin on tracheal and vascular smooth muscle in the dog, in vivo and in vitro.
- Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs.
- Effects of a new anti-inflammatory imidazole derivative, fenflumizole, on platelet aggregation in the rabbit.